Casadei Gardini Andrea and Frassineti Giovanni Luca
Background: Here we report a case of complete response in patient with Metastatic Breast Cancer treated by metronomic Chemotherapy.
Case presentation: A 51 years old woman underwent righy mastectomy in may 2008. She performed firstline chemotherapy with doxorubicin every 21 days. The CT revaluation after ten cycle showed a partial response to treatment. It was decided to stop the treatment with doxorubicin and to start a metronomic therapy with cyclophosphamide 50 mg daily orally and Methotrexate 2.5 mg twice daily. After two months of this maintenance treatment, the CT scan showed a complete response.
The metronomic treatment is still ongoing, and after 45 months the patient maintains a complete response.
Conclusion: This clinical case also highlights how suitable metronomic chemotherapy can be as maintenance therapy, allowing long-term treatment with no relevant toxicity.
Share this article
Journal of Blood & Lymph received 443 citations as per Google Scholar report
